USMLE/COMLEX - Step 2 - Acromegaly
Pathophysiology
Acromegaly is a rare hormonal disorder that results from the excessive production of growth hormone in adults, typically caused by a benign tumor in the pituitary gland. Excessive GH production increases insulin-like growth factor-1 (IGF-1) levels in the body, which causes tissue overgrowth, metabolic disturbances, and cardiovascular and neurological complications. The metabolic changes result from the effects of GH and IGF-1 on glucose metabolism.
Symptoms
Enlarged hands and feet
Protruding jaw and brow
Thickened skin
Deepening of the voice
Sleep apnea and snoring
Findings
Enlarged hands and feet
Protruding jaw and brow
Thickened skin
Coarse facial features
Deepening of the voice
Sleep apnea and snoring
Excessive sweating and body odor
Headaches, fatigue, and weakness
Joint pain and stiffness
Menstrual irregularities in women
Erectile dysfunction in men
Diagnosis
Insulin-like growth factor-1 test
Growth hormone suppression test
Magnetic resonance imaging
Visual field testing
Bone density scan
Treatment
The treatment of acromegaly can involve various approaches, including:
1. Transsphenoidal surgery: The primary treatment for acromegaly is the surgical removal of the pituitary adenoma causing excess growth hormone production. Transsphenoidal surgery is the preferred approach, which involves removing the adenoma through the nose and sphenoid sinus.
2. Radiation therapy: Radiation therapy may be used as a primary treatment or in combination with surgery for residual or recurrent tumors.
3. Medical therapy: Medical therapy is used as primary therapy for patients who are not candidates for surgery or radiation or as an adjunctive treatment after surgery or radiation. Medications that are commonly used include somatostatin analogs (e.g., octreotide, lanreotide), dopamine agonists (e.g., cabergoline), and growth hormone receptor antagonists (e.g., pegvisomant).